tiprankstipranks
Trending News
More News >
Ascelia Pharma AB (SE:ACE)
:ACE
Sweden Market

Ascelia Pharma AB (ACE) Ratios

Compare
2 Followers

Ascelia Pharma AB Ratios

SE:ACE's free cash flow for Q3 2025 was kr―. For the 2025 fiscal year, SE:ACE's free cash flow was decreased by kr and operating cash flow was kr―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.15 1.35 2.30 4.29 10.94
Quick Ratio
2.15 1.35 2.30 4.11 10.94
Cash Ratio
1.94 1.21 1.74 3.99 10.42
Solvency Ratio
-3.00 -1.29 -8.49 -3.45 -4.87
Operating Cash Flow Ratio
-1.73 -1.01 -10.09 -3.34 -4.64
Short-Term Operating Cash Flow Coverage
-7.73 -2.49 0.00 0.00 23.44
Net Current Asset Value
kr 35.38Mkr 21.74Mkr 16.19Mkr 123.16Mkr 248.95M
Leverage Ratios
Debt-to-Assets Ratio
0.07 0.18 0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.09 0.32 0.01 <0.01 <0.01
Debt-to-Capital Ratio
0.08 0.24 0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.34 1.79 1.17 1.21 1.08
Debt Service Coverage Ratio
-3.58 -2.06 -7.73K -2.71K 25.49
Interest Coverage Ratio
-5.44 -9.03 -7.92K -3.06K -1.79K
Debt to Market Cap
0.02 0.16 0.00 0.00 >-0.01
Interest Debt Per Share
0.21 0.61 0.03 0.02 0.05
Net Debt to EBITDA
0.65 0.74 0.19 1.13 2.02
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
99.56%99.88%99.71%98.55%97.21%
EBT Per EBIT
114.61%117.61%98.82%90.58%93.89%
Return on Assets (ROA)
-75.62%-56.79%-125.51%-60.04%-37.75%
Return on Equity (ROE)
-112.15%-101.37%-147.03%-72.55%-40.90%
Return on Capital Employed (ROCE)
-88.18%-86.29%-148.87%-81.20%-44.73%
Return on Invested Capital (ROIC)
-81.14%-65.21%-146.70%-79.89%-44.03%
Return on Tangible Assets
-138.86%-95.45%-364.32%-81.25%-45.55%
Earnings Yield
-31.31%-50.75%-96.18%-26.09%-12.80%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.00
Payables Turnover
0.00 0.20 0.69 0.25 1.42
Inventory Turnover
0.00 0.00 0.00 0.57 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
0.00 -1.84K -530.62 -853.04 -257.21
Days of Sales Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 636.31 0.00
Days of Payables Outstanding
0.00 1.84K 530.62 1.49K 257.21
Operating Cycle
0.00 0.00 0.00 636.31 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.48 -1.16 -3.76 -3.72 -3.54
Free Cash Flow Per Share
-0.48 -1.16 -3.76 -3.72 -3.54
CapEx Per Share
<0.01 0.00 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-944.42 0.00 0.00 -1.93K -3.07K
Capital Expenditure Coverage Ratio
-944.42 0.00 0.00 -1.93K -3.07K
Operating Cash Flow Coverage Ratio
-6.56 -2.47 -119.62 -258.81 -70.43
Operating Cash Flow to Sales Ratio
0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-17.11%-39.85%-111.58%-24.92%-11.85%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-3.07 -1.97 -1.04 -3.83 -7.81
Price-to-Sales (P/S) Ratio
0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
3.11 2.00 1.53 2.78 3.20
Price-to-Free Cash Flow (P/FCF) Ratio
-5.63 -2.51 -0.90 -4.01 -8.44
Price-to-Operating Cash Flow Ratio
-5.41 -2.51 -0.90 -4.02 -8.44
Price-to-Earnings Growth (PEG) Ratio
-0.53 0.04 0.06 -1.83 -4.90
Price-to-Fair Value
3.11 2.00 1.53 2.78 3.20
Enterprise Value Multiple
-3.14 -1.59 -0.86 -2.68 -5.64
Enterprise Value
262.72M 107.82M 92.84M 353.93M 723.89M
EV to EBITDA
-3.29 -1.59 -0.86 -2.68 -5.64
EV to Sales
0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
-4.88 -1.72 -0.73 -2.82 -6.21
EV to Operating Cash Flow
-4.88 -1.72 -0.73 -2.83 -6.21
Tangible Book Value Per Share
0.32 0.40 0.51 3.68 7.61
Shareholders’ Equity Per Share
0.83 1.46 2.20 5.37 9.34
Tax and Other Ratios
Effective Tax Rate
<0.01 <0.01 <0.01 0.01 0.03
Revenue Per Share
0.00 0.00 0.00 0.00 0.00
Net Income Per Share
-0.84 -1.48 -3.24 -3.90 -3.82
Tax Burden
1.00 1.00 1.00 0.99 0.97
Interest Burden
1.19 1.18 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.64 0.93 1.16 0.85 0.84
Currency in SEK